Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results.
For best results when printing this announcement, please click on link below: Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl Appointment of Frank Vargo, VP, Treasurer, to Interim CFO effective January 1, 2027 Emergent BioSolutions Inc. (NYSE: EBS) today announced that Richard S
CFO Richard S. Lindahl will retire effective Dec. 31, 2026. VP and Treasurer Frank Vargo will become interim CFO on Jan. 1, 2027, and Lindahl will advise through Mar. 31, 2027.
The company said Vice President and Treasurer Frank Vargo will become interim CFO effective January [date not fully provided].
Emergent BioSolutions CFO Richard S. Lindahl will retire effective December 31, 2026. Frank Vargo, vice president and treasurer, will become interim CFO effective January 1, 2027. Lindahl will serve as senior executive advisor from January 1 through March 31, 2027, to support the transition. Disclaimer: This news brief